Emirates Drug Establishment approves new indications for 'Guselkumab' for treating patients with Crohn’s disease

The Emirates Drug Establishment (EDE) has approved new indications for Guselkumab, making the UAE the second country globally to authorise the treatment for Crohn’s disease. Guselkumab is set to improve treatment opportunities for patients across the UAE and the wider region. As a significant addit...